Mobocertinib (TAK788, AP32788) 是一种研究用的TKI,是有效的、选择性的 epidermal growth factor receptor (EGFR) 和 HER2 突变体的临床前抑制剂。Mobocertinib (TAK788) 是一种抗肿瘤药。 Information Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor ofepidermal growth factor receptor (EGFR)andHER2mutations. Mobocertinib (TAK788) is an antineoplastic agent. Targets EGFR ; HER2
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Mobocertinib (TAK788)
CAS number:1847461-43-1 molecular formula:C32H39N7O4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | Isopropyl 2-(5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenylamino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate | s6813 | XYC46143 | MFCD32669806 | NCGC00016493-02 | propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-meth | ||
| CAS number | 1847461-43-1 | molecular formula | C32H39N7O4 |
| molecular weight | 585.7 g/mol | Exact mass | - |
| PSA | 114.000 Ų | logp | 5.252 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





